| 2015 |
Tsai JN, Uihlein AV, Burnett-Bowie S-AM, Neer RM, Zhu Y, Derrico N, Lee H, Bouxsein ML, Leder BZ. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study. J Bone Miner Res. January 2015;30(1):39-45. |
19 |
17 |
| 2017 |
Tsai JN, Nishiyama KK, Lin D, Yuan A, Lee H, Bouxsein ML, Leder BZ. Effects of denosumab and teriparatide transitions on bone microarchitecture and estimated strength: the DATA-Switch HR-pQCT study. J Bone Miner Res. October 2017;32(10):2001-2009. |
14 |
13 |
| 2021 |
Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Leder BZ, Tsai JN. Effects of combination denosumab and high‐dose teriparatide administration on bone microarchitecture and estimated strength: the DATA‐HD HR‐pQCT study. J Bone Miner Res. January 2021;36(1):41-51. |
1 |
1 |
| 2021 |
Ramchand SK, David NL, Lee H, Eastell R, Tsai JN, Leder BZ. Efficacy of zoledronic acid in maintaining areal and volumetric bone density after combined denosumab and teriparatide administration: DATA-HD study extension. J Bone Miner Res. May 2021;36(5):921-930. |
1 |
0 |
| 2023 |
Ramchand SK, David NL, Lee H, Bruce M, Bouxsein ML, Tsai JN, Leder BZ. The effect of zoledronic acid on bone microarchitecture and strength after denosumab and teriparatide administration: DATA-HD study extension. J Bone Miner Res. January 2023;38(1):26-34. |
0 |
0 |
| 2013 |
Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, Burnett-Bowie S-AM, Neer RM, Leder BZ. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet. July 6, 2013;382(9886):50-56. |
25 |
19 |
| 2015 |
Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie S-AM. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet. September 19-25, 2015;386(9999):1147. |
25 |
22 |